PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?

Por Simon, Sylvain, Labarriere, Nathalie
Publicado no Oncoimmunology (2017)

Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation

Por Bobinet, Mathilde, Vignard, Virginie, Florenceau, Laetitia, Lang, Francois, Labarriere, Nathalie, Moreau-Aubry, Agnès
Publicado em 2013

MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients

Por Bobinet, Mathilde, Vignard, Virginie, Rogel, Anne, Khammari, Amir, Dreno, Brigitte, Lang, Francois, Labarriere, Nathalie
Publicado em 2012

A Processed Pseudogene Codes for a New Antigen Recognized by a Cd8(+) T Cell Clone on Melanoma

Por Moreau-Aubry, Agnès, Le Guiner, Soizic, Labarrière, Nathalie, Gesnel, Marie-Claude, Jotereau, Francine, Breathnach, Richard
Publicado em 2000

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency

Por Godet, Yann, Moreau-Aubry, Agnès, Guilloux, Yannik, Vignard, Virginie, Khammari, Amir, Dreno, Brigitte, Jotereau, Francine, Labarriere, Nathalie
Publicado em 2008

IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens

Por Charpentier, Maud, Croyal, Mikael, Carbonnelle, Delphine, Fortun, Agnès, Florenceau, Laetitia, Rabu, Catherine, Krempf, Michel, Labarrière, Nathalie, Lang, François
Publicado no Oncotarget (2016)

The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Bona Fide Polycistronic mRNA Containing Functional IRES Sequences

Por Carbonnelle, Delphine, Vignard, Virginie, Sehedic, Delphine, Moreau-Aubry, Agnes, Florenceau, Laetitia, Charpentier, Maud, Mikulits, Wolfgang, Labarriere, Nathalie, Lang, François
Publicado em 2013

Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway

Por Godefroy, Emmanuelle, Manches, Olivier, Dréno, Brigitte, Hochman, Tsivia, Rolnitzky, Linda, Labarrière, Nathalie, Guilloux, Yannick, Goldberg, Judith, Jotereau, Francine, Bhardwaj, Nina
Publicado em 2011

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features

Por Simon, Sylvain, Wu, Zhong, Cruard, J., Vignard, Virginie, Fortun, Agnes, Khammari, Amir, Dreno, Brigitte, Lang, Francois, Rulli, Samuel J., Labarriere, Nathalie
Publicado no Front Immunol (2018)

Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment

Por Paolini, Léa, Poli, Caroline, Blanchard, Simon, Urban, Thierry, Croué, Anne, Rousselet, Marie-Christine, Le Roux, Sarah, Labarrière, Nathalie, Jeannin, Pascale, Hureaux, José
Publicado no J Immunother Cancer (2018)

Low Levels of Natural Anti-α-N-Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19

Por Breiman, Adrien, Ruvoën-Clouet, Nathalie, Deleers, Marie, Beauvais, Tiffany, Jouand, Nicolas, Rocher, Jézabel, Bovin, Nicolai, Labarrière, Nathalie, El Kenz, Hanane, Le Pendu, Jacques
Publicado no Front Microbiol (2021)

CD4CD8αα Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease

Por Sarrabayrouse, Guillaume, Bossard, Céline, Chauvin, Joe-Marc, Jarry, Anne, Meurette, Guillaume, Quévrain, Elodie, Bridonneau, Chantal, Preisser, Laurence, Asehnoune, Karim, Labarrière, Nathalie, Altare, Frédéric, Sokol, Harry, Jotereau, Francine
Publicado em 2014

Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells

Por Rabu, Catherine, Rangan, Laurie, Florenceau, Laetitia, Fortun, Agnès, Charpentier, Maud, Dupré, Emilie, Paolini, Léa, Beauvillain, Céline, Dupel, Estelle, Latouche, Jean-Baptiste, Adotevi, Olivier, Labarrière, Nathalie, Lang, François
Publicado no Oncoimmunology (2019)

Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model

Por Capitao, Marisa, Perrin, Justine, Simon, Sylvain, Gouard, Sébastien, Chouin, Nicolas, Bruchertseifer, Frank, Morgenstern, Alfred, Rbah-Vidal, Latifa, Chérel, Michel, Scotet, Emmanuel, Labarrière, Nathalie, Guilloux, Yannick, Gaschet, Joëlle
Publicado no Cancers (Basel) (2021)

CD40L confers helper functions to human intra-melanoma class-I-restricted CD4(+)CD8(+) double positive T cells

Por Parrot, Tiphaine, Oger, Romain, Benlalam, Houssem, Raingeard de la Blétière, Diane, Jouand, Nicolas, Coutolleau, Anne, Preisser, Laurence, Khammari, Amir, Dréno, Brigitte, Guardiola, Philippe, Delneste, Yves, Labarrière, Nathalie, Gervois, Nadine
Publicado no Oncoimmunology (2016)

Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes

Por Marotte, Lucine, Simon, Sylvain, Vignard, Virginie, Dupre, Emilie, Gantier, Malika, Cruard, Jonathan, Alberge, Jean-Baptiste, Hussong, Melanie, Deleine, Cecile, Heslan, Jean-Marie, Shaffer, Jonathan, Beauvais, Tiffany, Gaschet, Joelle, Scotet, Emmanuel, Fradin, Delphine, Jarry, Anne, Nguyen, Tuan, Labarriere, Nathalie
Publicado no J Immunother Cancer (2020)

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.

Por Delaunay, Tiphaine, Violland, Mathilde, Boisgerault, Nicolas, Dutoit, Soizic, Vignard, Virginie, Münz, Christian, Gannage, Monique, Dréno, Brigitte, Vaivode, Kristine, Pjanova, Dace, Labarrière, Nathalie, Wang, Yaohe, Chiocca, E. Antonio, Boeuf, Fabrice Le, Bell, John C., Erbs, Philippe, Tangy, Frédéric, Grégoire, Marc, Fonteneau, Jean-François
Publicado no Oncoimmunology (2017)

PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy

Por Simon, Sylvain, Voillet, Valentin, Vignard, Virginie, Wu, Zhong, Dabrowski, Camille, Jouand, Nicolas, Beauvais, Tiffany, Khammari, Amir, Braudeau, Cécile, Josien, Régis, Adotevi, Olivier, Laheurte, Caroline, Aubin, François, Nardin, Charles, Rulli, Samuel, Gottardo, Raphael, Ramchurren, Nirasha, Cheever, Martin, Fling, Steven P, Church, Candice D, Nghiem, Paul, Dreno, Brigitte, Riddell, Stanley R, Labarriere, Nathalie
Publicado no J Immunother Cancer (2020)

Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance

Por Gauttier, Vanessa, Pengam, Sabrina, Durand, Justine, Biteau, Kevin, Mary, Caroline, Morello, Aurore, Néel, Mélanie, Porto, Georgia, Teppaz, Géraldine, Thepenier, Virginie, Danger, Richard, Vince, Nicolas, Wilhelm, Emmanuelle, Girault, Isabelle, Abes, Riad, Ruiz, Catherine, Trilleaud, Charlène, Ralph, Kerry, Trombetta, E. Sergio, Garcia, Alexandra, Vignard, Virginie, Martinet, Bernard, Glémain, Alexandre, Bruneau, Sarah, Haspot, Fabienne, Dehmani, Safa, Duplouye, Pierre, Miyasaka, Masayuki, Labarrière, Nathalie, Laplaud, David, Le Bas-Bernardet, Stéphanie, Blanquart, Christophe, Catros, Véronique, Gouraud, Pierre-Antoine, Archambeaud, Isabelle, Aublé, Hélène, Metairie, Sylvie, Mosnier, Jean-François, Costantini, Dominique, Blancho, Gilles, Conchon, Sophie, Vanhove, Bernard, Poirier, Nicolas
Publicado no J Clin Invest (2020)